** Shares of e-cigarette and vape maker Smoore International
Holdings Ltd 6969.HK and ophthalmic therapies developer
Ocumension Therapeutics 1477.HK more than doubled from their
IPO prices on their first day of trade in Hong Kong on Friday
** Smoore trades as high as HK$29.20 ($3.77) per share, up
135.5% from the IPO price of HK$12.40 apiece, and is the second
most actively traded stock by turnover on the Hong Kong bourse
** Shenzhen-based Smoore offered 574 mln shares at high end
of the indicated range of HK$9.60-12.40 each, raising HK$7.12
bln ($918.7 mln) to expand, upgrade production capacity
urn:newsml:reuters.com:*:nL4N2ED1PR
** Another newcomer, Ocumension Therapeutics, trades as high
as HK$43 per share, up 193.3% from the IPO price of HK$14.66
each, and ranks the ninth most actively traded by turnover
** Shanghai-based Ocumension sold 106 mln shares in Hong
Kong IPO, raising HK$1.55 bln for products development,
acquisition of manufacturing facility urn:newsml:reuters.com:*:nL4N2ED0QJ
** Beijing-based cancers drug maker Immunotech Biopharm Ltd
6978.HK soars as much as 53.3% from the IPO price to HK$16.86
** Zhejiang-based project management firm Greentown
Management Holdings Co Ltd 9979.HK trades as high as HK$3.33
on debut, up 33.2% from IPO price of HK$2.50 apiece
** Online advertiser Adtiger Corp Ltd 1163.HK surges 48.8%
from IPO price to HK$1.28 on debut, and property manager Zhenro
Services Group Ltd 6958.HK rises 14.5% to HK$5.21
** The Hang Seng China enterprises index .HSCE declines
1.6%, while the benchmark index .HSI falls 1.2%
($1 = 7.7503 Hong Kong dollars)
(Reuters Messaging: donny.kwok.thomsonreuters.com@reuters.net)